GSK-3β inhibitor 1 (b)

CAS No. 3367-88-2

GSK-3β inhibitor 1 (b)( —— )

Catalog No. M24282 CAS No. 3367-88-2

GSK-3β inhibitor 1 is a glycogen synthase kinase 3β (GSK-3β) inhibitor and demonstrates high antidiabetic efficacy.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 115 In Stock
10MG 192 In Stock
25MG 354 In Stock
50MG 530 In Stock
100MG 759 In Stock
500MG 1557 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    GSK-3β inhibitor 1 (b)
  • Note
    Research use only, not for human use.
  • Brief Description
    GSK-3β inhibitor 1 is a glycogen synthase kinase 3β (GSK-3β) inhibitor and demonstrates high antidiabetic efficacy.
  • Description
    GSK-3β inhibitor 1 is a glycogen synthase kinase 3β (GSK-3β) inhibitor and demonstrates high antidiabetic efficacy.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    PI3K/Akt/mTOR signaling
  • Target
    GSK-3
  • Recptor
    GSK-3β
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    3367-88-2
  • Formula Weight
    222.24
  • Molecular Formula
    C14H10N2O
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:49 mg/mL?(220.48 mM;?Need ultrasonic)
  • SMILES
    O=C1Nc(cccc2)c2C1=Cc1ncccc1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Lozinskaya NA, et al. Synthesis and biological evaluation of 3-substituted 2-oxindole derivatives as new glycogen synthase kinase 3β inhibitors. Bioorg Med Chem. 2019 May 1;27(9):1804-1817.
molnova catalog
related products
  • BIO

    A cell-permeable derivative of 6-bromoindirubin that displays selective inhibition of GSK-3 with IC50 of 5 nM.

  • Cazpaullone

    Cazpaullone (9-Cyano-1-azapaullone) is a derivative of 1-Azakenpaullone, a potent, selective GSK3β inhibitor with IC50 of 8 nM.

  • Bikinin

    Bikinin (Abrasin) is a plant GSK-3/Shaggy-like kinases inhibitor that activates brassinosteroid (BR) signaling downstream of the BR receptor.